Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mattanswers
    Member
    • Oct 2009
    • 65

    #1

    Cuffdiff dilemma

    I have 4 samples, each in triplicate (A1, A2, A3; B1, B2, B3; C1, C2, C3; D1, D2, D3)

    When I use Cuffdiff to compare within each sample, say A1 to A2 or B2 to B3, I get DE genes and most of the 30K or so genes have FPKM values. This is true for all 12 .bam files, in other words there is a similar result (most genes have FPKM values and status of OK) for all in-sample comparisons.


    When I use Cuffdiff to compare between samples, say A1,A2 to C2,C3 or A1,A2,A3 to D1,D2,D3, I get results only for A1,A2 to B2,B3, but for A2,A3 to B2,B3, the status for almost all genes is NOTEST.

    The only genes with status OK and FPKM values are on mitochondria and chloroplast DNA. This same result occurs for all other between sample comparisons. (Only A1,A2 to B2,B3 works).

    The same merged.gtf and genome.fa files are being used in all Cuffdiff's. Only the accepted_hits.bam files are changing.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...